<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9</volume><submitter>Fagbadebo FO</submitter><pubmed_abstract>The mitochondrial outer membrane (MOM)-anchored GTPase Miro1, is a central player in mitochondrial transport and homeostasis. The dysregulation of Miro1 in amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) suggests that Miro1 may be a potential biomarker or drug target in neuronal disorders. However, the molecular functionality of Miro1 under (patho-) physiological conditions is poorly known. For a more comprehensive understanding of the molecular functions of Miro1, we have developed Miro1-specific nanobodies (Nbs) as novel research tools. We identified seven Nbs that bind either the N- or C-terminal GTPase domain of Miro1 and demonstrate their application as research tools for proteomic and imaging approaches. To visualize the dynamics of Miro1 in real time, we selected in</pubmed_abstract><journal>Frontiers in molecular biosciences</journal><pagination>835302</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8960383</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Nanobody-Based Toolset to Monitor and Modify the Mitochondrial GTPase Miro1.</pubmed_title><pmcid>PMC8960383</pmcid><pubmed_authors>Jarjour G</pubmed_authors><pubmed_authors>Zittlau K</pubmed_authors><pubmed_authors>Bartlick N</pubmed_authors><pubmed_authors>Froehlich T</pubmed_authors><pubmed_authors>Nueske S</pubmed_authors><pubmed_authors>Scholz A</pubmed_authors><pubmed_authors>Rothbauer U</pubmed_authors><pubmed_authors>Kaiser PD</pubmed_authors><pubmed_authors>Fagbadebo FO</pubmed_authors><pubmed_authors>Wagner TR</pubmed_authors><pubmed_authors>Traenkle B</pubmed_authors><pubmed_authors>Macek B</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Nanobody-Based Toolset to Monitor and Modify the Mitochondrial GTPase Miro1.</name><description>The mitochondrial outer membrane (MOM)-anchored GTPase Miro1, is a central player in mitochondrial transport and homeostasis. The dysregulation of Miro1 in amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD) suggests that Miro1 may be a potential biomarker or drug target in neuronal disorders. However, the molecular functionality of Miro1 under (patho-) physiological conditions is poorly known. For a more comprehensive understanding of the molecular functions of Miro1, we have developed Miro1-specific nanobodies (Nbs) as novel research tools. We identified seven Nbs that bind either the N- or C-terminal GTPase domain of Miro1 and demonstrate their application as research tools for proteomic and imaging approaches. To visualize the dynamics of Miro1 in real time, we selected in</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-04-08T17:57:17.01Z</modification><creation>2025-04-06T21:53:57.959Z</creation></dates><accession>S-EPMC8960383</accession><cross_references><pubmed>35359597</pubmed><doi>10.3389/fmolb.2022.835302</doi></cross_references></HashMap>